The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index®.The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. This ETF offers 2x daily short leverage to the broad-based NASDAQ Biotechnology Index.
Latest shares articles
Forex CFDs: Understanding currency forwards vs spot markets
Spot or forward? These two forex markets behave differently, and now you can trade both with us as forex CFDs. Here’s how they work, and what sets them apart.
14:48, 31 July 2025
Crypto CFDs: Popular cryptocurrencies for trading
Discover which cryptocurrencies are trending for CFD trading in 2025 – from bitcoin to newly listed coins like SUI and PEPE.
10:46, 31 July 2025
Trading the Nasdaq 100 Amidst Big Tech Earnings
Microsoft and Meta notably impressed powering the tech-heavy index higher in the futures market, but it’s two down and two more to go as both Apple and Amazon are next.
07:04, 31 July 2025
Ripple price prediction: Third-party price target
Ripple, launched in 2012 with the XRP Ledger, aims to make cross-border payments faster and cheaper using its native token, XRP. Backed by financial institutions and a strong market presence, it remains a major crypto asset by market cap.
14:34, 30 July 2025
Ratings and Reviews
Ratings and Reviews
